Experienced CFO and M&A Advisor
Resume:
SUMMARY
Eight years as a hands-on CFO of a high-growth, technology- and software-enabled global energy services company, with experience leading during a period of exponential revenue growth, transition to profitability, and subsequent sale to a publicly-traded company.
Nine years of mergers & acquisitions advisory experience at leading investment banks, advising public and private companies on acquisitions, mergers, divestitures, corporate sales, spin-offs, leveraged buyouts, and fairness opinions.
MBA in Finance from The Wharton School at the University of Pennsylvania.
BA in Business Economics from UCLA.
Extensive experience presenting to fellow executives, investors and boards of directors.
PROFESSIONAL EXPERIENCE
Chief Financial Officer
QUEST INTEGRITY GROUP, Seattle, WA (www.questintegrity.com)
Quest is a $75 million revenue pipeline inspection company with 280 employees in 11 subsidiaries globally.
October 2008 – September 2016 (8 years)
Provided hands-on financial and strategic leadership in all areas, including accounting, financial strategy, budgeting, forecasting, reporting, analysis, capital allocation, tax, treasury, compliance, internal controls, and accounting policies and procedures
Led company from its start-up days in 2008 with $14M revenue and 50 employees, through eight years of growth to $75M annual revenue and 280 employees in 11 countries internationally.
Led company to profitability, culminating in a sale to a publicly-traded company in November 2010 for $45M
Led global implementation of a worldwide general ledger and project accounting system (9 currencies in 11 countries worldwide)
Led global implementation of SalesLogix customer relations management system
Led company through external financial audits, internal audits, implementation of Foreign Corrupt Practices Act (FCPA) compliance, and implementation of Sarbanes-Oxley (SOX) internal controls
Established detailed financial reporting, budgeting, and forecasting practices to improve transparency and enhance accountability throughout the organization
Led company through its first-ever bank debt financing and associated financial statement and collateral audit by lender
Primary financial liaison to banks, prospective investors, external accountants, attorneys, and tax authorities
Director, Healthcare Mergers & Acquisitions
MERRILL LYNCH & CO., San Francisco, CA (www.merrilllynch.com)
August 2005 – April 2008 (2 years, 8 months)
Led and managed teams of investment bankers, attorneys, and clients in the execution of a wide variety of M&A transactions, including acquisitions, mergers, divestitures, and spin-offs
Played central role in all aspects of business origination, resulting in approximately $34M of aggregate fees
Mentored, trained, and recruited junior bankers
Selected transaction experience includes:
$3.5B separation of Abraxis BioScience into two independent publicly traded companies, effected through a tax-free spin-off of the proprietary oncology business into a new public company
$1.7B separation of PDL BioPharma into two independent publicly traded companies, effected through a taxable spin-off of the biotechnology drug development operations into a new public company
$600M acquisition by Illumina of gene sequencing company Solexa in a stock-for-stock transaction
$240M divestiture of PDL BioPharma’s antibody manufacturing facility to Genmab A/S
$200M divestiture of PDL BioPharma’s oncology assets to Japan-based Otsuka Pharmaceuticals
$170M divestiture of PDL BioPharma’s cardiovascular assets to venture capital-backed EKR Therapeutics
$150M cross-border merger of Bioness and Israel-based Neuromuscular Electrical Stimulation Systems, Ltd.
Divestiture of BioMarin Pharmaceutical’s Orapred® drug to venture capital-backed Alliant Pharmaceuticals
Vice President, Mergers & Acquisitions
CONWAY, DEL GENIO, GRIES & CO., New York City, NY (www.cdggroup.com)
CDG is a boutique restructuring and M&A advisory firm based in New York.
August 2002 – August 2005 (3 years)
Played key team leadership role in crisis management engagement for cable company Adelphia Communications Corp. during its $18B bankruptcy restructuring, one of the most complex bankruptcies in history. Critical team member responsible for constructing business plan and creating detailed financial model to determine debtor-in-possession financing needs – two key deliverables for presentation to creditors.
Together with CDG’s Head of M&A, developed the Firm’s non-distressed company M&A practice from scratch. Engaged in all aspects of transaction execution and business development, including idea generation, presentation structure and delivery. Mentored, trained, and recruited junior bankers.
Associate, Mergers Acquisitions & Restructurings Department
MORGAN STANLEY & CO., Los Angeles, CA (www.morganstanley.com)
June 2000 – August 2002 (2 years, 2 months)
Executed a variety of M&A transactions, including mergers, acquisitions, divestitures, company sales, spin-offs, leveraged buyouts, and fairness opinions
Together with senior bankers, contributed to all aspects of new business origination, including new business presentations and complex financial modeling
Selected transaction experience includes:
$3.2B merger of Del Monte Foods with assets from H. J. Heinz Co. in Reverse Morris Trust simultaneous spin/merge transaction
$600M sale of network marketing company Herbalife to Whitney & Co. and Golden Gate Capital
$500M debt restructuring for health insurer PacifiCare Health Systems
$300M sale of packaged salad-maker Fresh Express to Performance Food Group
$225M acquisition by Headwaters Incorporated of coal recycling company Industrial Services Group
$170M divestiture of CAIS Internet’s CAIS Software Solutions subsidiary to Cisco Systems
$55M acquisition by The Copley Press of newspaper assets from Journal Register Company
EDUCATION / CREDENTIALS
THE WHARTON SCHOOL, UNIVERSITY OF PENNSYLVANIA
Master of Business Administration (MBA) in Finance
1999
UNIVERSITY OF CALIFORNIA, LOS ANGELES
Bachelor of Arts cum laude in Business Economics
1994
Candidate for Certified Public Accountant (CPA)
State of California
Expected Spring 2017
TRANSACTION EXPERIENCE
Year
Acquirer
Target
Target
Industry
Deal
Value
Transaction Description
Role
2016
Quest Integrity Group, LLC
Turbinate International, B.V.
Energy Services
$10M
Acquisition
All aspects of transaction (structuring, negotiations, due diligence, pro forma analysis)
2013
Quest Integrity Group, LLC
Digital Insight Ltd.
Energy Services
$2M
Acquisition
All aspects of transaction (structuring, negotiations, due diligence, pro forma analysis)
2012
Quest Integrity Group, LLC
PWI, Inc.
Energy Services
$2M
Acquisition
All aspects of transaction (structuring, negotiations, due diligence, pro forma analysis)
2010
Team, Inc.
Quest Integrity Group, LLC
Energy Services
$45M
Sale of company
All aspects of transaction (valuation, structuring, negotiations)
2008
---
PDL BioPharma, Inc.
Biotechnology
$1.7B
Separation into two public companies (spin-off)
Provided advice to senior management/board; led project execution team
2008
Genmab A/S
PDL BioPharma, Inc. (antibody manufacturing facility)
Biotechnology
$240M
Divestiture of manufacturing facility
Provided advice to senior management/board; led project execution team
2008
EKR Therapeutics, Inc.
PDL BioPharma, Inc. (cardiovascular assets)
Specialty Pharmaceuticals
$170M
Divestiture of cardiovascular assets
Provided advice to senior management/board; led project execution team
2007
Otsuka Pharmaceutical Co., Ltd.
PDL BioPharma, Inc. (oncology assets)
Specialty Pharmaceuticals
$200M
Divestiture of oncology assets
Provided advice to senior management/board; led project execution team
2007
---
Abraxis BioScience, Inc.
Biotechnology, Generic Pharmaceuticals
$3.5B
Separation into two public companies (spin-off)
Provided advice to senior management; led project execution team
2007
Bioness, Inc.
Neuromuscular Electrical Stimulation Systems, Ltd.
Medical Technology
$150M
Valuation opinion
Provided advice to senior management; led team in all aspects of opinion
2006
Illumina, Inc.
Solexa, Inc.
Life Sciences Tools
$600M
Acquisition
Provided advice to senior management/board; led project execution team
2006
---
PDL BioPharma, Inc.
Biotechnology
N/A
Shareholder rights plan
Provided advice to senior management/board; led project team
2006
Alliant Pharmaceuticals, Inc.
BioMarin Pharmaceutical, Inc. (Orapred drug)
Specialty Pharmaceuticals
N/A
Asset divestiture
Provided advice to senior management; led project execution team
2003
---
Adelphia Communications Corporation
Media / Telecom
$18B
Crisis management advisor
Lead team member responsible for debtor-in-possession financing model and business plan, two essential deliverables for presentation to creditors
2002
Headwaters Incorporated
Industrial Services Group, Inc.
Renewable Energy
$225M
Acquisition
Valuation analysis, pro forma financial analysis, fairness opinion
2002
H. J. Heinz Company (selected assets)
Del Monte Foods Company
Food
$3.2B
Simultaneous spin-off and merger
Valuation analysis, pro forma financial analysis, fairness opinion
2002
---
PacifiCare Health Systems, Inc.
Health Insurance
$500M
Balance sheet restructuring
Advised board on variety of strategic and financial alternatives
2002
Whitney & Co. and Golden Gate Capital
Herbalife International, Inc.
Network Marketing
$600M
Fairness opinion
Prepared and managed all aspects of fairness opinion
2001
Performance Food Group Company
Fresh International Corporation
Food
$300M
Sale of company
Executed all aspects of auction process and fairness opinion
2000
Cisco Systems, Inc.
CAIS Internet, Inc. (CAIS Software Solutions subsidiary)
Technology
$170M
Divestiture of subsidiary
Valuation and other analyses to support negotiating position
2000
The Copley Press, Inc.
Selected newspaper assets of Journal Register Company
Media
$55M
Acquisition of assets
Pro forma financial analysis, due diligence
2000
Cardinal Health, Inc.
Bergen Brunswig Medical Corp.
Medical Products Distribution
$180M
Divestiture of subsidiary
Prepared offering memorandum, negotiations
2000
Grupo Sanborns, S.A. de C.V.
CompUSA Inc.
Retail
$1.2B
Sale of company
Valuation, fairness opinion
Note: bold text represents party advised
Contact this candidate